Skip to main content
. 2017 Dec 11;34(1):108–114. doi: 10.1007/s12291-017-0723-9

Fig. 2.

Fig. 2

Change in study parameters after treatment in various treatment groups. Figure shows group wise change in parameters in the study subjects after 3 months of treatment for PCOS depending on their presenting complaints. a Significant increase in serum Omentin-1in OCP treated group II, b significant decrease in serum PSA in Lifestyle modification group I, OCP treated group II, MPA treated group IV, c significant decrease in FG score in OCP treated group II and clomiphene citrate treated group III, d no change in BMI in any of the groups. *P < 0.05; Pre—Baseline data; Post—Post treatment data